E. Ristori

Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status

I. Screpanti, G. Giannini, L. Frati, 2000, British Journal of Cancer.

HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.

L. Di Marcotullio, I. Screpanti, M. Crescenzi, 1999, Cancer research.

Responsiveness Cell Lines and Tumors and Affect Retinoic Acid Genes Are Expressed in Neuroblastoma HMGI-C and HMGI ( Y ) Updated

I. Screpanti, M. Crescenzi, G. Giannini, 1999 .

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.

G. Giannini, E. Ricevuto, A. Gulino, 2006, Critical reviews in oncology/hematology.

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

I. Screpanti, G. Giannini, E. Ricevuto, 2006, Breast Cancer Research and Treatment.

Human MRE11 is inactivated in mismatch repair‐deficient cancers

Alessandra Viel, Fabio Cerignoli, Marco Crescenzi, 2002, EMBO reports.

Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability

I. Screpanti, A. Viel, G. Giannini, 2004, Oncogene.

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.

A Gulino, I. Screpanti, G. Giannini, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.